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ABSTRACT
Objective: Osteoarthritis can be treated by taking oral supplements containing compounds that can nourish bones and joints such as hyaluronic acid, 
methylsulfonylmethane (MSM), chondroitin, glucosamine, and collagen. This study aimed to develop and validate tests for analyzing two compounds, 
namely, hyaluronic acid and MSM, simultaneously and to determine both their levels in a mixed sample.
Methods: Hyaluronic acid derivatization was carried out using fluorenylmethyloxycarbonyl chloride and then analyzed by liquid chromatography 
with fluorescence detection, while MSM was analyzed using gas chromatography. After the development of optimal conditions for each separation, 
system suitability tests were developed and calibration curves used for tests of accuracy and precision as well as for level determination. Hyaluronic 
was detected at an excitation wavelength of 255 nm and emission wavelength of 330 nm. The mobile phase used was acetonitrile-acetate pH 4.2 (1: 4) 
with a flow rate of 1.0 mL/min.
Results: The developed method was linear (r=0.9983) in the range of 5–50 ppm and the limits of detection (LOD) and quantitation (LOQ) were 3.55 
and 11.84 ppm, respectively. The initial column temperature for MSM analysis was 110°C and the mobile phase used was nitrogen gas at a flow rate of 
0.8 mL/min. The method was linear (r=0.9998) in the range of 4000–15,000 ppm and the LOD and LOQ were 332.90 and 1109.67 ppm, respectively.
Conclusion: A simulated sample containing both compounds was assessed to contained 98.63% hyaluronic acid and 99.35% MSM.
Keywords: Hyaluronic acid, Methylsulfonylmethane, High-performance liquid chromatography, Gas chromatography, Fluorenylmethyloxycarbonyl 
chloride, Component, Optimization, Validation.
INTRODUCTION
Food supplements are products that contain nutrients and excipients 
and are available as capsules, tablets, powders, or liquids; they are used 
in cases where dietary insufficiency of their ingredients can lead to ill 
health [1]. Food supplements are only complementary, and not intended 
to be used as substitutes for a normal diet. These supplements usually 
contain chemical compounds that function as nutrients in the body and 
they can aid in supplying the specific nutritional needs of those with 
certain health conditions. For example, protein supplementation is 
used to prevent joint pain and help tighten the skin [2].
Two compounds that are often used in supplements to prevent these 
conditions are hyaluronic acid and methylsulfonylmethane (MSM), both 
of which can nourish bones and joints [1]. There are a number such 
supplement products sold to treat the symptoms of osteoarthritis and 
these usually contain glucosamine sulfate, chondroitin sulfate, MSM, 
Celadrin, nattokinase, hyaluronic acid, black catechu, skullcap, Boswellia 
serrata, and curcumin [3]. This study developed analytical methods for 
only hyaluronic acid and MSM because separation all these components 
require high-performance gradient liquid chromatography, while only 
isocratic high-performance liquid chromatography (HPLC) was available.
Hyaluronic acid exists in various molecular sizes in biological tissues 
and fluids and can be degraded by both normal physiological or 
pathological conditions [4]. It consists of linear macromolecular chains 
of repeated glucuronic acid and N-acetyl-D-glucosamine subunits that 
form glucosamine when hydrolyzed [5]. Hyaluronic acid molecules of 
different weights have different rheological and biological properties, 
and this, coupled to its intrinsic biocompatibility and viscoelastic 
physical character, means that it has been used as a treatment for 
osteoarthritis [6]. Thus, hyaluronic acid is commonly used as a 
supplement to maintain joint health and to control tissue hydration [7].
Methylsulfonylmethane is an organosulfur compound that is commonly 
used as a food supplement for the prevention of metabolic diseases 
since the amount of MSM and sulfur in the body decreases with age [8].
Hyaluronic acid does not contain any chromophores but can be 
derivatized with fluorescent compounds. Reagents that are often used for 
such derivatization before analysis include orthophtalaldehyde, phenyl 
isothiocyanate (PITC), and 9-fluorenylmetoxycarbonyl chloride [3].
Hyaluronic acid has previously been analyzed are using high-
performance size-exclusion liquid chromatography [9], while a study 
using HPLC conducted by Harmita (2015) used a silica phase with 
phosphoric and potassium hydroxide in conjunction with UV detectors. 
Methylsulfonylmethane can be analyzed by gas chromatography (GC), 
with the 39th edition of the United States Pharmacopeia Edition 39 
providing a method using dimethylpolysiloxane gum columns with a 
mobile phase of helium gas and flame ionization detection.
Here, we conducted an analysis of a mixture of hyaluronic acid and 
methylsulfonylmethane using HPLC in dimethyl sulfoxide with 
fluorescence detection for hyaluronic acid, and GC with flame ionization 
detection for methylsulfonylmethane analysis. Hyaluronic acid was 
derivatized with 9-fluoroenylmetoxycarbonil chloride, which was 
chosen because it can react with primary and secondary amine groups.
MATERIALS AND METHODS
Materials
Chemicals were purchased from the following suppliers: Hyaluronic 
acid standard (Sigma-Aldrich); methylsulfonylmethane standard 
(Merck); magnesium stearate (Merck); Amylum Oryzae (Merck); 
9-fluoroenilmetoxicarbonyl chloride (Merck); glacial acetic acid 
(Merck); chloride acid (Merck); methanol pro HPLC (Merck); aqua pro 
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injection (Ikapharmindo Putramas); aquadest (Brataco); acetonitrile 
pro HPLC (Merck); NaOH (Merck); boric acid (Merck); anhydrous 
sodium acetate (Merck); nitrogen (Merck); and hydrogen (Merck).
Equipment
The HPLC (Shimadzu®) consisted of pumps, Shimadzu® C18 columns, 
RF 20A fluorescence detectors, manual injectors, a computer data 
processor, and HPLC syringes (SGE®, Australia). A Shimadzu® GC model 
GC-17A equipped with flame ionization detector, a capillary column 
with a length of 30 m, inner diameter of 0.53 mm, and film thickness 
of 5 µm with stationary phase G2 was used with a 10 µl micro-syringe 
(Hamilton Co.Nevada®).
Procedures
Standard hyaluronic acid solution
Two hundred milligrams of hyaluronic acid standard was dissolved in 
100 mL of 0.1 N HCl and diluted to a concentration of 10 μg/mL.
Standard methylsulfonylmethane solution
Four milligrams of methylsulfonylmethane was dissolved in 1 mL of 
methanol, sonicated at 50°C for 1 min, and cooled to room temperature.
Wavelength optimization
The hyaluronic acid standard (300 µL) was pipetted into a test tube and 
300 µl of borate buffer and 300 μL of 1.5 mM fluorenylmethyloxycarbonyl 
chloride (FMOC-Cl) reagent added. The mixture was vortexed for 20 s 
and allowed to stand for 2 min before injection of 20 μL into the HPLC to 
determine the excitation and emission wavelengths. This was achieved 
by varying excitation wavelengths at 255 nm and using three emission 
wavelengths (320, 325, and 330 nm). The selected wavelengths were 
those that produced the largest peak area.
Determination of optimal analytic conditions
A standard solution of hyaluronic acid with a concentration of 
50 μL/mL as much as 100 μL each into the test tube add 100 µl of borate 
buffer pH 9.3, the solution is then added FMOC-Cl reagent to the selected 
volume. The mixture was vortexed for 20 s and allowed to react before 
HPLC analysis. Twenty microliter aliquots were analyzed using various 
combinations of the mobile phase of acetate (pH 4.2)-acetonitrile at 1:2, 
2:3, and 1:4 and with different flow rates of 0.8, 1.0, or 1.2 mL/min.
One microliter of a standard solution of methylsulfonylmethane at a 
concentration of 4000 ppm was injected into the GC, and determination 
of optimal analysis conditions was performed by programing various 
initial column temperatures of the 100°C, 110°C, or 120°C and 
various flow rates of 0.8, 1.0, or 1.2 mL/min. The initial temperature 
was increased by 1°C/min to 250°C and the injector and detector 
temperatures were set to 250°C. The retention time, area, follow-up 
factor, number of theoretical plates, column efficiency (HETP), and 
resolution were determined for each condition, and the one that had 
the shortest retention time, the largest number of theoretical plates 
(N), the smallest HETP, the smallest follow-up factor (Tf), and the best 
separation with a resolution of 1.5 or more was selected.
Precision of the hyaluronic acid system
One hundred microliters of standard solution of hyaluronic acid with a 
concentration of 20 μL/mL was added to 100 μL borate buffer pH 9.3, 
the derivatization was carried out under the selected conditions. 
Twenty microliters of this solution were then injected into the 
HPLC 6 times and analyzed using the optimized method. The results 
were used to determine the coefficient of variance (% KV), which 
was found to be below 2%. The parameters seen were based on the 
separation between two adjacent peaks (R), the follow-up factor (Tf), 
peak discharge retention time, the column efficiency (HETP), and the 
number of theoretical plates (N).
A standard solution of methylsulfonylmethane at a concentration of 
4000 ppm was vortexed to homogeneity and 1 µL injected into the GC 
and analyzed using the optimized method.
Validation of analytical methods
One microliter of 1000 mL/mL of hyaluronic acid was placed into a 
10 mL flask and used to produce a 100-ppm solution, which was then 
used to produce solution of 10, 20, 30, 40, and 50 μg/mL. Samples were 
then derivatized and 20.0 μL of each was analyzed. A plot of peak area 
(y) versus concentration (x) produced a straight line with a correlation 
coefficient (r) of ≥0.999 (Fig. 1).
Different volumes (200 µL, 400 µL, 800 µL, 1000 µL, 1200 µL, and 
1500 µL) of the 50,000 ppm methylsulfonylmethane standard solution 
were each added to 5 mL volumetric flasks, which were brought to volume 
using mobile phase solvent and then mixed to produce concentrations 
of 2000, 4000, 8000, 10,000, 12,000, and 15,000 ppm. One microliter 
of each solution was then injected into the GC and analyzed using the 
optimized conditions. The data were then used to produce a curve of 
peak area versus concentration. Result shown in Fig. 2.
Accuracy and precision tests for hyaluronic acid were carried out by 
analyzing simulated samples, which were produced by adding pure 
analytes added to the pharmaceutical vehicle. The concentrations used 
were low, medium, and high, namely, concentrations of 80%, 100%, 
and 120% of the target concentration. The 100% sample was made by 
dissolving 4 mg of the matrix of capsule fillers in a mixture of 20 mg 
of hyaluronic acid and 32 mg of methylsulfonylmethane. The 80% 
concentration was prepared by dissolving 3.2 mg of matrix in a mixture 
of 16 mg hyaluronic acid and 25.6 mg methylsulfonylmethane. The 
120% concentration was produced by dissolving 4.8 mg of matrix in a 
mixture of 24 mg hyaluronic acid and 38.4 mg methylsulfonylmethane. 
All samples were dissolved in 100 mL 0.1 N HCl then pipette 1 ml 
and put  into a 10 mL  flask. Samples were  filtered  through a 0.45 μm 
membrane and 300 μL of  each  solution was  added  to 300 μL borate 
buffer pH 9.3  and 300 μL FMOC-Cl 1.5 mM (in  acetonitrile)  then  the 
sample was filtered using a filter. Twenty microliters of each sample 
were injected into the HPLC in triplicate and the percent recovery 
(% recovery) and % KV were calculated using calibration curves to 
determine concentrations. Accuracy was considered acceptable if the 
percentage of recovery (% UPK) lays between 98% and 102% of target. 
Precision was considered acceptable if % KV was 2% or less.
Accuracy and precision tests for methylsulfonylmethane were 
conducted as for hyaluronic acid. The 100% concentration was 
produced by dissolving 5 mg of capsule matrix with 5 mg hyaluronic 
acid and 20 mg methylsulfonylmethane. The 80% concentration was 
Fig. 1: Calibration Curve for hyaluronic acid
Fig. 2: Calibration curve for methylsulfonylmethane
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produced by dissolving 5 mg of matrix with a mixture of 4 mg hyaluronic 
acid and 16 mg methylsulfonylmethane. The 120% concentration was 
produced by dissolving 5 mg of matrix with 6 mg hyaluronic acid 
and 24 mg methylsulfonylmethane, methanol was used as a solvent 
and samples were shaken until dissolved. Each sample was passed 
through  a  0.45  μm  filter  and  1  mL  placed  into  a  10  mL  volumetric 
flask, which was filled to volume with n-hexane. One microliter of each 
sample was analyzed in triplicate, and the recover (% recovery) and 
% KV calculated using calibration curves to determine concentrations. 
Accuracy was considered acceptable if the percentage of recovery (% 
UPK) lays between 98% and 102% of target. Precision was considered 
acceptable if % KV was 2% or less.
Selectivity
The standard hyaluronic acid solution was derivatized and then 
20 μL was injected into HPLC and the chromatograms examined for any 
differences in retention time between the sample and the standard and 
to determine whether or not another peak appeared at the hyaluronic 
acid retention time in the sample solution.
The 40,000 ppm methylsulfonylmethane standard solution of was 
vortexed to homogeneity and 1 µL injected into the GC. The same 
volume of a matrix solution was next injected and the chromatograms 
examined to determine whether any matrix components eluted at the 
same time as methylsulfonylmethane.
RESULTS AND DISCUSSION
The results of method optimization for hyaluronic acid are summarized 
in Tables 1-3. Based on the data, a wavelength of 330 nm with a mobile 
phase with a ratio 1:4 and a flow rate of 1.0 mL/min were selected as 
the optimal conditions because these produced relatively fast retention 
times, a number of theoretical plates with a relatively small HETP, and a 
tailing factor close to one.
Results for methylsulfonylmethane analysis optimization are shown 
in Tables 4-6. This showed that higher initial column temperatures 
and faster flow rates produced smaller retention times. The initial 
temperature of the column used was chosen to be 110°C with a flow rate 
of 0.8 mL/min because this produced relatively faster retention times, 
quite a high number of theoretical plates, a relatively small HETP, and 
a tailing factor of close to one. The 120°C temperature was not chosen 
because it resulted in the peak of the chromatogram at the retention time 
with the peak of the solvent chromatogram used so that it was feared 
that the proximity of the two chromatographic peaks could disrupt the 
chromatogram peak of methylsulfonylmethane compound. The 1.0 mL/
min and 1.2 mL/min flow rates were not chosen because they resulted 
in an unfavorable separation between the substance and solvent peaks.
The conformity tests were carried out to qualify the optimized method 
by running six consecutive tests under the same conditions. This needs 
Table 2: Effect of variations in the composition on the mobile phase with respect to retention time, peak area, theoretical plate, tailing 
factor, and HETP of hyaluronic acid derivatives
Mobile phase Mobile phase ratio Retention time (min) Peak area (μV/s) Theoretical plates (N) Tailing factor (Tf) HETP (cm)
Acetonitrile-acetic 
buffer pH 4.2
1:2 41.312 2346676 2049 0.769 7368.27
1:4 5.999 5688541 1019 1.241 147.22
2:3 20.637 8123089 1626 1.563 851.63
Table 3: Relationship of flow rate to retention time, peak area, theoretical plate, tailing factor, and HETP of hyaluronic acid derivatives
Flow rate (mL/min) Retention time (min) Peak area (μV/s) Theoretical plates (N) Tailing factor (Tf) HETP (cm)
0.8 7.476 2955712 1305 1.221 114.99
1.0 5.999 3245385 1289 1.210 112.99
1.2 5.026 3157540 694 1.217 216.29
HETP: Height equivalent to a theoretical plate
Table 4: The relationship between retention time, peak area, number of theoretical plates, column efficiency, resolution, and tailing 
factor for methylsulfonylmethane at various flow rates and an initial column temperature of column 100°C












100°C 0.8 3.837 47392 14810.85 0.996 2.03
3.845 34775 25638.96 0.979 1.17
3.826 33991 13886.27 0.982 2.16
1.0 3.057 50043 19742.45 1.101 1.52
3.056 50109 16555.80 1.069 1.81
3.076 50178 11936.14 0.825 2.51
1.2 2.594 50164 10021.11 1.358 2.99
2.599 42272 8338.191 1.363 3.60
2.621 62094 9347.068 0.924 3.21
HETP: Height equivalent to a theoretical plate
Table 1: Effect of emission wavelength variations on retention time, peak area, theoretical plate, tailing factor, and HETP of hyaluronic 
acid derivatives









255 320 5.990 2909568 892 1.219 168.14
325 5.981 4819277 869 1.207 172.60
330 5.999 6855595 889 1.193 168.73
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Table 5: The relationship between retention time, peak area, number of theoretical plates, column efficiency, resolution, and tailing 
factor for methylsulfonylmethane at various flow rates and an initial column temperature of column 110°C












110°C 0.8 3.412 50311 30283.17 0.994 0.99
3.386 50875 26149.43 1.002 1.15
3.396 50656 24017.07 0.856 1.25
1.0 2.734 50240 17840.12 0.822 1.68
2.722 50037 207320.2 0.932 0.14
2.722 50008 20763.31 0.976 1.44
1.2 2.296 51349 8779.278 0.828 3.42
2.308 49178 11011.42 0.654 2.72
2.306 51359 13757.95 0.903 2.18
HETP: Height equivalent to a theoretical plate
Table 6: The relationship between retention time, peak area, number of theoretical plates, column efficiency, resolution, and tailing 
factor for methylsulfonylmethane at various flow rates and an initial column temperature of column 120°C












120°C 0.8 3.077 55413 20548.17 0.957 3.41
3.048 56478 18564.26 1.203 2.72
3.092 52336 22654.84 0.941 1.46
1.0 2.524 58412 23154.15 1.025 1.50
2.486 55648 26465.26 1.335 3.00
2.598 54852 24515.21 1.051 1.80
1.2 2.054 53215 26648.04 1.326 1.90
1.984 52156 19354.51 1.512 2.98
2.012 50123 23645.35 1.320 2.87
HETP: Height equivalent to a theoretical plate
















20 6.463 1643597 2583 0.993 58.08 1669780 18605.52 1.11
6.459 1683699 2477 0.976 60.55
6.432 1685824 2418 0.872 62.03
6.409 1651481 2317 0.838 64.73
6.391 1668269 2164 0.902 69.32
6.423 1685811 2302 0.895 65.77
HETP: Height equivalent to a theoretical plate
















4000 3.327 54266 22161.562 0.993 0.14 54285.17 57.1084 0.11
3.336 54231 21209.208 1.294 0.14
3.347 54271 13836.078 0.976 0.22
3.338 54325 15080.732 1.32 0.2
3.338 54380 22954.957 1.296 0.13
3.347 54238 17840.273 1.193 0.17
HETP: Height equivalent to a theoretical plate
to be done because there will be variations on the results to be obtained 
so that it can be calculated and proven whether the results obtained are 
still in accordance with the objectives of the analysis and the applicable 
provisions or not. The data obtained for the two compounds passed 
the requirements for repeatability, with the coefficients of variation for 
both being below 2% (0.1% for methylsulfonylmethane and 1.11% for 
hyaluronic acid). The data shown in Tables 7 and 8.
Linear calibration curves are used to calculate the concentrations of 
compounds in a sample. A calibration curve for methylsulfonylmethane 
was produced that contained six points between 2000 and 15,000 
μg/mL.  The  linear  equation  was  y=15.596x−8673.5,  where  x  is  the 
concentration and y is the chromatogram peak area, and the correlation 
coefficient was 0.9998 (Table 9).
For hyaluronic acid compounds, a 6-point curve between 5 and 
50 μg/mL produced a line with the equation y = 75714x−1859406 and 
a correlation coefficient of 0.9983 Table 10.
Accuracy is a value that describes the closeness of test results to the 
actual level of the analyte in the sample. Accuracy can be defined as the 
% recovery, i.e., the percentage of the test result relative to actual content 
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of the sample and should fall within 98–120% to be acceptable [9]. In 
this study, this was conducted by producing simulated samples by from 
mixtures of the two analytes with appropriate pharmaceutical excipients. 
The mixtures were first prepared, derivatized (for hyaluronic acid) and 
then analyzed using high-performance fluorescence detector liquid 
chromatography. Methylsulfonylmethane was prepared then analyzed 
using by GC. The simulated samples were produced at three different 
concentrations, namely, 80%, 100%, and 120%, which corresponded to 
hyaluronic acid concentrations of 16 μg/mL, 20 μg/mL, and 24 μg/mL, 
while the simulated methylsulfonylmethane samples contained of 
3200 μg/mL, 4000 μg/mL, and 4800 μg/mL, respectively. Recovery of 
methylsulfonylmethane ranged between 100.37% and 101.50%, while 
those for hyaluronic acid ranged between 98.59% and 100.42%, both 
of which were considered excellent. Result shown in Tables 11 and 12.
Table 10: Calibration curve data, LOD, and LOQ for hyaluronic acid
Concentration (μL/mL) Peak area (μV/s) yi=a+bx (y−yi)2 S(y/x) LOD (μg/mL) LOQ (μg/mL)
5 339912 237976 0390948096 85086.4131 3.55 11.84
10 603443 616546 71688609
20 245385 373686 2209808004
30 74688 130826 151475044
40 925521 887966 410378025
50 685411 645106 624493025
N=6 ∑=28958790803
LOD: Limit of detection , LOQ: Limit of quantification
Table 9: Calibration curve data, LOD, and LOQ for methylsulfonylmethane
Concentration (μL/mL) Peak area (μV/s) yi=a+bx (y−yi)2 S(y/x) LOD (μg/mL) LOQ (μg/mL)
2000 20793 22518.5 2977350.25 1730.6455 332.9 1109.67
4000 54105 53710.5 155630.25
8000 118345 116094.5 5064750.25
10,000 148495 147286.5 1460472.25
12,000 177244 178478.5 1523990.25
15,000 224373 225266.5 798342.25
N=6 ∑=11980535.5
LOD: Limit of detection, LOQ: Limit of quantification
Table 11: Accuracy and precision data for hyaluronic acid
Concentration (μg/mL) Peak area (μV/s) Measured concentration (μg/mL) % Recovery Average Standard deviation KV (%)
8 2456552 7.886864 98.59 99.03 0.7858 0.79
2464738 7.994981 99.94
2456437 7.885345 98.57
10 2619691 10.04154 100.42 100.34 0.105 0.1
2618220 10.02211 100.22
2619478 10.03872 100.39
12 2770009 12.02688 100.22 99.51 0.6614 0.66
2758155 11.87931 98.92
2762367 11.92595 99.38
Table 12: Accuracy and precision data for methylsulfonylmethane
Concentration (μg/mL) Peak area (μV/s) Measured concentration (μg/mL) % Recovery Average Standard deviation KV (%)
3200 41736 3232.207 101.01 100.96 0.5696 0.56
41416 3211.689 100.37
41983 3248.044 101.5






4800 66776 4837.747 100.79 100.86 0.0689 0.07
66879 4844.351 100.92
66832 4841.338 100.86
Table 13: Quantification data for hyaluronic acid levels in supplements
Concentration (μg/mL) Peak area (μV/s) Measured concentration (μg/mL) % Recovery Average Standard deviation KV (%)
10 2609213 9.9031 99.03 98.63 0.3488 0.35
2604953 9.8469 98.47
2604378 9.8393 98.39
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Precision reflects the reproducibility of results from multiple analyzes 
of the same material and is measured by % KV. In general, % KV values 
below 2% are considered acceptable [9]. Here, the % KV was 0.07%–
0.56% for methylsulfonylmethane and 0.10%–0.79% for hyaluronic 
acid, both of which were considered acceptable.
To determine the levels of the two compounds, the samples were 
prepared containing both. Hyaluronic acid was derivatized using FMOC-
Cl first and then analyzed HPLC to yield a sample content of 98.63%. 
Meanwhile, GC indicated a methylsulfonylmethane content of 99.35%. 
Result shown in Tables 13 and 14.
CONCLUSION
The optimum condition for analysis of hyaluronic acid by HPLC was 
with an excitation wavelength 255 nm and emission wavelength of 
330 nm and with a mobile phase of acetonitrile-acetate pH 4.2 (1:4) 
at a flow rate of 1.0 mL/min. The optimum conditions for the analysis 
of methylsulfonylmethane by GC were with an initial temperature of 
column 110°C and a subsequent increase of 1°C/min to a temperature 
of 200°C, with an injector temperature of 250°C, a detector temperature 
of 250°C, and a nitrogen carrier gas flow rate of 0.80 mL/min.
The validation conducted here consisted of selectivity, linearity, 
detection and quantitation limit, and accuracy and precision tests. 
Both methods fulfilled the applicable criteria with respect to these 
analyses. For hyaluronic acid, the correlation coefficient was 0.9983 in 
a concentration range of 5–50 μg/mL and the LOD and LOQ values were 
3.55 μg/mL and 11.84 μg/mL, respectively. Accuracy values as assessed 
by recover were 98.59–100.42% and precision as expressed by % KV 
was below 2%. For methylsulfonylmethane, the correlation coefficient 
was 0.9998 in the range of 2000–15,000 μg/mL and the LOD and LOQ 
were 332.90 μg/mL and 1109.67 μg/mL, respectively. Accuracy ranged 
between 100.37% and 101.50% and precision was below 2%.
A simulated sample containing both compounds was assessed to 
contained 98.63% hyaluronic acid and 99.35% methylsulfonylmethane.
For further research, hydrolysis of hyaluronic acid compounds is 
needed to obtain a more sensitive method.
REFERENCES
1. Cañibano-Hernández A, Saenz Del Burgo L, Espona-Noguera A, 
Orive G, Hernández RM, Ciriza J, et al. Hyaluronic acid enhances 
cell survival of encapsulated insulin-producing cells in alginate-based 
microcapsules. Int J Pharm 2019;557:192-8.
2. Tokita Y, Okamoto A. Hydrolytic degradation of hyaluronic acid. 
Polym Degrad Stab 1995;48:269-73.
3. Faust HJ, Sommerfeld SD, Rathod S, Rittenbach A, Ray Banerjee S, 
Tsui BM, et al. A hyaluronic acid binding peptide-polymer system for 
treating osteoarthritis. Biomaterials 2018;183:93-101.
4. Gocmen G, Gonul O, Oktay NS, Yarat A, Goker K. The antioxidant 
and anti-inflammatory efficiency of hyaluronic acid after third molar 
extraction. J Craniomaxillofac Surg 2015;43:1033-7.
5. Lin A, Nguy CH, Shic F, Ross BD. Accumulation of 
methylsulfonylmethane in the human brain: Identification by 
multinuclear magnetic resonance spectroscopy. Toxicol Lett 
2001;123:169-77.
6. Basu, P, Sunny S, Maier C. Estrogenic and antiestrogenic activities 
of commercial dietary supplements containing herbal ingredients and 
isoflavones. Int J Pharm Pharm Sci 2016;8:307-12.
7. Volpi N. Hyaluronic acid and chondroitin sulfate unsaturated 
disaccharides analysis by high-performance liquid chromatography 
and fluorimetric detection with dansylhydrazine. Anal Biochem 
2000;277:19-24.
8. Vatansever B, Binici B. A quantitative method for the measurement of 
hydrolyzed type-I collagen protein in dietary supplement sirup using 
HPLC-SEC-UV technique. J Chem Metrol 2015;1:1-15.
9. Podder AK. Qualitative and quantitative analysis of sildenafil in 
traditional medicines and dietary supplements. Asian J Pharm Clin Res 
2014;7:25-30.
Table 14: Quantification data for methylsulfonylmethane levels in supplements
Concentration (μg/mL) Peak area (μV/s) Measured concentration (μg/mL) % Recovery Average Standard deviation KV (%)
4000 53592 3992.402 99.81 99.35 0.4010 0.40
53141 3963.484 99.09
53179 3965.921 99.15
